Winnipeg's HSC Hepatology clinic manages Hepatitis B patients from across Manitoba, including patients from Winnipeg's large Filipino, Korean, and Indigenous communities — all groups with above-average HBV prevalence. Tavin TDF 300mg provides Winnipeg patients with proven long-term Hepatitis B viral suppression at significantly reduced cost compared to private pharmacy pricing for branded Viread.
Manitoba Health covers Hepatitis B antivirals through the Pharmacare programme for eligible residents, but newer arrivals, temporary residents, and those self-funding treatment benefit significantly from affordable generic Tavin. The province's significant Filipino community — from a country with 16% Hepatitis B prevalence — creates consistent long-term HBV treatment demand in Winnipeg.
Visit medshopy.com or WhatsApp +91 82650 41513.
Manitoba Health covers Hepatitis B antivirals through the Pharmacare programme for eligible residents, but newer arrivals, temporary residents, and those self-funding treatment benefit significantly from affordable generic Tavin. The province's significant Filipino community — from a country with 16% Hepatitis B prevalence — creates consistent long-term HBV treatment demand in Winnipeg.
Visit medshopy.com or WhatsApp +91 82650 41513.
Is Hepatitis B screening recommended for all immigrants to Canada, and what happens if it's positive?Yes — Canadian immigration medical examinations include Hepatitis B surface antigen testing for most applicants, and additional testing may be done depending on country of origin and risk factors. If a positive result is found, it does not generally bar immigration but does trigger referral to medical follow-up in Canada. Once in Canada, Hepatitis B-positive immigrants should be referred to a hepatologist or gastroenterologist for full assessment — including HBV DNA viral load, liver function tests, HBeAg status, and liver fibrosis assessment — to determine whether antiviral treatment is needed. Not all HBsAg-positive individuals need immediate treatment; some are in the immune-tolerant phase where monitoring without treatment is appropriate. Winnipeg physicians use established guidelines to make this determination for each patient individually.
